← All news

Startups

These Melanoma Patients Got a Vaccine Made for Their Own Tumors. 2 Years Later, 82% Are Still Cancer-Free

An apparent leak prompted Merck and Moderna to release the full trial results ahead of schedule, but investors puzzlingly greeted the good news by sending the companies’ stock prices down.

Read the full story on Gizmodo.

Read at source (opens in a new tab)

Latest from Gizmodo

Latest digest

Week 42 EN

Open the digest

Sources

72 active sources

27 Turkish · 45 English

All sources